1887

Journal of General Virology header logo

Volume 71, Issue 12

Liposomes Modulate Human Immunodeficiency Virus Infectivity Free

Abstract

We have investigated the effects of the fusion of liposomes with human immunodeficiency virus type 1 (HIV-1va) on the ability of the virus to infect CD4 and CD4 cells. Fluorescence dequenching measurements indicated that HIV-1 fuses with liposomes composed of either cardiolipin (CL) or N-[2,3-(dioley- loxy) propyl]- -trimethyl ammonium chloride (DOTMA) but not appreciably with dioleoylphospha- tidylcholine (DOPC) liposomes. Pre-incubation of HIV-1 with DOTMA liposomes enhanced virus production (measured by p24 antigen production in the culture medium and ) in CD4 A3.01 and H9 cells in a concentration-dependent manner, but did not mediate the infection of the CD4 cell line, K562. Pre-incubation of HIV-1 with between 10 and 30 | μ - DOTMA liposomes, and subsequent incubation with A3.01 cells, resulted in the production of about 30-fold greater levels of virus than controls. The presence of DOTMA liposomes during the incubation of A3.01 cells with HIV-1 enhanced the infectivity of the virus up to 90-fold compared to controls. Conversely, preincubation of HIV-1 with CL liposomes inhibited infection of A3.01 cells, dependent on the concentration of liposomes; DOPC liposomes did not alter the infectivity of the virus under any of the incubation conditions. Our results thus indicate that fusion of HIV-1 with liposomes alters the ability of the virus to infect its target cells.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1990
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-12-2899
1990-12-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/12/JV0710122899.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-12-2899&mimeType=html&fmt=ahah

References

  1. Aloia R. C., Jensen F. C., Curtain C. C., Mobley O. W., Gordon L. M. 1988; Lipid composition and fluidity of the human immunodeficiency virus. Proceedings of the National Academy of Sciences U.S.A.: 85900–904
     [Google Scholar]
  2. Bangham A. D., Standish M. M., Watkins J. C. 1965; Diffusion of univalent ions across lamellae of swollen phosholipids. Journal of Molecular Biology 13:238–252
     [Google Scholar]
  3. Bartlett G. R. 1959; Phosphorous assay in column chromatography. Journal of Biological Chemistry 234:466–468
     [Google Scholar]
  4. Bradford M. M. 1976; A rapid and sensitive method for the quantitation of microgram quantitities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
     [Google Scholar]
  5. CENTERS FOR DISEASE CONTROL 1988; 1988 Agent summary statement for human immunodeficiency virus and report on laboratory- acquired infection with human immunodeficiency virus. Morbidity and Mortality Weekly Report 37 (supplement no. S-4), 1-17
     [Google Scholar]
  6. Cheng-Mayer C., Rutka J. T., Rosenblum M. L., McHugh T., Stites D. P., Levy J. A. 1987; Human immunodeficiency virus can productively infect cultured human glial cells. Proceedings of the National Academy of Sciences U.S.A.: 843526–3530
     [Google Scholar]
  7. Chesebro B., Wehrly K. 1988; Development of a sensitive quantitative focal assay for human immunodeficiency virus infec- tivity. Journal of Virology 62:3779–3788
     [Google Scholar]
  8. Chesebro B., Buller R., Portis J., Wehrly K. 1990; Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. Journal of Virology 64:215–221
     [Google Scholar]
  9. Clapham P. R., Weber J. N., Whitby D., McIntosh K., Dalgleish A. G., Maddon P. J., Deen K. C., Sweet R. W., Weiss R. A. 1989; Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature; London: 337368–370
     [Google Scholar]
  10. Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. 1984; The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature; London: 312763–767
     [Google Scholar]
  11. Debs R. J., Freedman L., Edmunds S., Gaensler K., Düzgüneş N., Yamamoto K. R. 1990; Regulation of gene expression in vivo by liposome-based delivery of transcription factors. Journal of Biological Chemistry 265:10189–10192
     [Google Scholar]
  12. Düzgüneş N., Wilschut J., Hong K., Fraley R., Perry C., Friend D. S., James T. L., Papahadjopoulos D. 1983; Physicochemical characterization of large unilamellar vesicles prepared by reverse-phase evaporation. Biochimica et biophysica acta 732:289–299
     [Google Scholar]
  13. Düzgüneş N., Goldstein J. A., Friend D. S., Feigner P. L. 1989; Fusion of liposomes containing a novel cationic lipid, N-[2,3-(dioleyloxy) propyl]-N,N,N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. Biochemistry 28:9179–9184
     [Google Scholar]
  14. Feigner P. L., Ringold G. M. 1989; Cationic liposome-mediated transfection. Nature; London: 337387–388
     [Google Scholar]
  15. Feigner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop J. P., Ringold G. M., Danielsen M. 1987; Lipofectin: a highly efficient, lipid-mediated DNA-transfec- tion procedure. Proceedings of the National Academy of Sciences U.S.A.: 847413–7417
     [Google Scholar]
  16. Folks T. M., Powell. D., Lightfoote. M., Koenig. S., Fauci. A. S., Benn. S., Rabson A., Daugherty D., Gendelman. H. E., Hoggan. M. D., Venkatesan. S., Martin. M. A. 1986; Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. Journal of Experimental Medicine 164:280–290
     [Google Scholar]
  17. Gabizon A., Papahadjopoulos D. 1988; Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proceedings of the National Academy of Sciences U.S.A.: 856949–6953
     [Google Scholar]
  18. Gartner S., Markovitz P., Markovitz D. M., Kaplan M. H., Gallo R. C., Popovic M. 1986; The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215–219
     [Google Scholar]
  19. Gowda S. D., Stein B. S., Mohagheghpour N., Benike C. J., Engleman E. G. 1988; Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. Journal of Immunology 142:773–780
     [Google Scholar]
  20. Harouse J. M., Kunsch C., Hartle H. T., Laughlin M. A., Hoxie J. A., Wigdahl B., Gonzales-Scarano F. 1989; CD4- independent infection of human neural cells by human immunodeficiency virus type 1. Journal of Virology 63:2527–2533
     [Google Scholar]
  21. Ho D. D., Rota T. R., Hirsch M. S. 1986; Infection of monocyte/macrophages by human T lymphotropic virus type III. Journal of Clinical Investigation 77:1712–1715
     [Google Scholar]
  22. Hoekstra D., De Boer T., Klappe K., Wilschut J. 1984; Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675–5681
     [Google Scholar]
  23. Hoffman A. D., Banapour B., Levy J. A. 1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326–335
     [Google Scholar]
  24. Hope M. J., Bally M. B., Webb G., Cullis P. R. 1985; Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochimica et biophysica acta 812:55–65
     [Google Scholar]
  25. Innes C. L., Smith P. B., Langenbach R., Tindall K. R., Boone L. R. 1990; Cationic liposomes (lipofectin) mediate retroviral infection in the absence of specific receptors. Journal of Virology 64:957–961
     [Google Scholar]
  26. Klappe K., Wilschut J., Nir S., Hoekstra D. 1986; Parameters affecting fusion between Sendai virus and liposomes. Role of viral proteins, liposome composition, and pH. Biochemistry 25:8252–8260
     [Google Scholar]
  27. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.-C., Montagnier L. 1984; T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature; London: 312767–768
     [Google Scholar]
  28. Larsen C., Alford D., Young L., Lee K.-D., McGraw T. P., Düzgüneş N. 1989; Fusion of simian immunodeficiency virus (SIVmac) with liposomes and erythrocyte ghosts. Abstracts of the V International Conference on AIDS p. 634 Montreal, Canada:
     [Google Scholar]
  29. Larsen C. E., Alford D. R., Young L. J. T., Mcgraw T. P., Düzgüneş N. 1990; Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghost membranes: effect of lipid composition, pH and calcium. Journal of General Virology 71:1947–1955
     [Google Scholar]
  30. Loyter A., Citovsky V., Blumenthal R. 1988; The use of fluorescence dequenching measurements to follow viral membrane fusion events. Methods of Biochemical Analysis 33:129–164
     [Google Scholar]
  31. McDougal J. S., Nicholson J. K. A., Cross G. D., Cort S. P., Kennedy M. S., Mawle A. C. 1986; Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. Journal of Immunology 137:2937–2944
     [Google Scholar]
  32. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. 1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348
     [Google Scholar]
  33. Misra R., Venables P. J. W., Plater-Zyberk C., Watkins P. F., Maini R. N. 1989; Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes. Clinical and Experimental Immunology 75:35–40
     [Google Scholar]
  34. Nara P. L., Hwang K. M., Rausch D. M., Lifson J. D., Eiden L. E. 1989; CD4 antigen-based antireceptor peptides inhibit infec-tivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle. Proceedings of the National Academy of Sciences U.S.A.: 867139–7143
     [Google Scholar]
  35. Ou C. Y., Kwok S., Mitchell S. W., Mack D. H., Sninsky J. J., Krebs J. W., Feorino P., Warfield D., Schochetman G. 1988; DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295–297
     [Google Scholar]
  36. Sattentau Q., Dalgleish A. G., Weiss R. A., Beverly P. C. L. 1986; Epitopes of the CD4 antigen and HIV infection. Science 234:1120–1123
     [Google Scholar]
  37. Schlegel R., Tralka S. T., Willingham M. C., Pastan I. 1983; Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?. Cell 32:639–646
     [Google Scholar]
  38. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. 1986; Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature; London: 322470–474
     [Google Scholar]
  39. Stegmann T., Hoekstra D., Scherphof G., Wilschut J. 1985; Kinetics of pH-dependent fusion between influenza virus and liposomes. Biochemistry 24:3107–3113
     [Google Scholar]
  40. Stegmann T., Nir S., Wilschut J. 1989; Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes. Biochemistry 28:1698–1704
     [Google Scholar]
  41. Szoka F., Olson F., Heath T., Vail W., Mayhew E., Papahadjopoulos D. 1980; Preparation of unilamellar liposomes of intermediate size (0·1–0·2 pm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochimica et biophysica acta 601:559–571
     [Google Scholar]
  42. Tateno M., Gonzales-Scarano F., Levy J. A. 1989; Human immunodeficiency virus can infect CD4-negative human fibroblas- toid cells. Proceedings of the National Academy of Sciences U.S.A.: 864287–4290
     [Google Scholar]
  43. Toyoshima K., Vogt P. K. 1969; Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 38:414–426
     [Google Scholar]
  44. Treat J., Greenspan A. R., Rahman A. 1989; Liposome encapsulated doxorubicin. Preliminary results of phase I and phase II trials. In Liposomes in the Therapy of Infectious Diseases and Cancer pp 353–365 Lopez-Berestein G., Fidler I. J. Edited by New York: Alan R. Liss;
     [Google Scholar]
  45. Weber J., Clapham P., McKeating J., Stratton M., Robey E., Weiss R. 1989; Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. Journal of General Virology 70:2653–2660
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-12-2899
Loading
Liposomes Modulate Human Immunodeficiency Virus Infectivity
J. Gen. Virol. 71, 2899 (1990); https://doi.org/10.1099/0022-1317-71-12-2899
/content/journal/jgv/10.1099/0022-1317-71-12-2899
/content/journal/jgv/10.1099/0022-1317-71-12-2899
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error